Evidence map›Paper›PMID 37085894›Full record

ArticleGenome biology2023

YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2.

Xiaotang Wang, Wei Fan, Na Li, Yan Ma, Mudi Yao, Guoqing Wang, Siyuan He, Wanqian Li, Jun Tan, Qi Lu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
67.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 244 citations in OpenAlex.

  1. Review
  2. Lactate Signal: Modulator of Cellular Energy Production and Anabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. The role of lactate in retinal health and disease: mechanisms and potential therapeutic strategies. A narrative review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Xiaotang Wang *The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wei Fan *The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Na LiSchool of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China.
Yan MaThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China.
Mudi YaoThe Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China.
Guoqing WangThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Siyuan HeThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wanqian LiThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jun TanThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qi LuThe Children's Hospital of Chongqing Medical University, Chongqing, China.
Shengping HouThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China. sphou828@163.com.ORCID 0000-0002-7796-8891
National Clinical Research Center for Digestive Diseases · CNNanjing Medical University · CNBeijing Tongren Hospital · CNChildren's Hospital of Chongqing Medical University · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOcular neovascularization is a leading cause of blindness. Retinal microglia have been implicated in hypoxia-induced angiogenesis and vasculopathy, but the underlying mechanisms are not entirely clear. Lactylation is a novel lactate-derived posttranslational modification that plays key roles in multiple cellular processes. Since hypoxia in ischemic retinopathy is a precipitating factor for retinal neovascularization, lactylation is very likely to be involved in this process. The present study aimed to explore the role of lactylation in retinal neovascularization and identify new therapeutic targets for retinal neovascular diseases.

resultsMicroglial depletion by the colony-stimulating factor 1 receptor (CSF1R) inhibitor PLX3397 suppresses retinal neovascularization in oxygen-induced retinopathy. Hypoxia increased lactylation in microglia and accelerates FGF2 expression, promoting retinal neovascularization. We identify 77 sites of 67 proteins with increased lactylation in the context of increased lactate under hypoxia. Our results show that the nonhistone protein Yin Yang-1 (YY1), a transcription factor, is lactylated at lysine 183 (K183), which is regulated by p300. Hyperlactylated YY1 directly enhances FGF2 transcription and promotes angiogenesis. YY1 mutation at K183 eliminates these effects. Overexpression of p300 increases YY1 lactylation and enhances angiogenesis in vitro and administration of the p300 inhibitor A485 greatly suppresses vascularization in vivo and in vitro.

conclusionsOur results suggest that YY1 lactylation in microglia plays an important role in retinal neovascularization by upregulating FGF2 expression. Targeting the lactate/p300/YY1 lactylation/FGF2 axis may provide new therapeutic targets for proliferative retinopathies.

Indexed as

Fibroblast Growth Factor 2MicrogliaRetinal NeovascularizationYY1 Transcription FactorAminopyridinesAnimalsHypoxiaLactatesMiceProtein Processing, Post-TranslationalPyrrolesTranscriptional ActivationUp-RegulationAminopyridinesFibroblast Growth Factor 2LactatespexidartinibPyrrolesYY1 Transcription FactorAngiogenesisLactylationPosttranslational modifications (PTMs)Retinal microgliaYY1

Identifiers

PMID37085894
PMCPMC10120156
OpenAlexW4366742265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.